This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Jan. 22, 2013 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the fourth quarter of 2012 on
Tuesday, February 12, 2013, before the market opens.
The Company will host a conference call at
10:00 AM ET on
Tuesday, February 12, 2013, during which Vanda management will discuss the financial results. To participate in the conference call, please dial 1-800-901-5248 (domestic) or 1-617-786-4512 (international) and use passcode 86594010.
The conference call will be broadcast simultaneously and archived on the Company's website,
www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on
Tuesday, February 12, 2013, beginning at
12:00 PM ET and will be accessible until
Tuesday, February 19, 2013, at
5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The passcode number is 89804635.
ABOUT VANDA PHARMACEUTICALS INC.:Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit
Company Contact: Cristina MurphySenior Communications Manager Vanda Pharmaceuticals Inc. (202) 734-3400
SOURCE Vanda Pharmaceuticals Inc.